CPHI vs RUN
China Pharma Holdings Inc (CPHI) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
CPHI currently screens at market cap $29.0M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the CPHI and RUN stock pages for the full models.
Not investment advice.